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ABSTRACT 
The kidney is complex vital organs, and has many functions. The main function it‘s removal of toxic and excess  substancesfrom the plasma, if 
there is any defect in the kidney like renal failure can disrupt  this function. The aim of this study was to determine the level of Zinc and Copper 
in Sudanese patient with chronic renal failure. This study was designed as case control, which includes 100 blood samples, a 60 from these 
sample were collected from patient with chronic renal failure and 40 samples were collected from health individual as control group and the 
sample is collected by using sterile disposable syringes and separated by centrifuge. Carried out in Ribat University Hospital in Khartoum state, 
during period from March to June 2018. And the plasma levels of zinc and copper determined by the use of atomic absorption 
spectrophotometer (OPERATOR’S MANUAL January 2003 VER 3.94 C), and the obtained results were analyzed by SPSS. The result of this study 
showed that there was significant decrease (p<0.05) in the plasma levels of zinc and copper in patient with chronic renal failure compared to the 
control subjects. The mean of plasma Zn was 0.3mg/l in test group and 0.7mg/l in control group with p. value of 0.002 and the mean of plasma 
Copper was 0.5mg/l in test group and 0.7mg/l in control group with p. value of 0.019. Also the study showed the gender and age of the patient, 
also the duration of the disease have no effect on the plasma level of zinc and copper (p 0.05). The study concludes that the plasma level of zinc 
and copper are low in patient with chronic renal failure. And the gender and age of the patient also the duration of disease have no significant 
effect on the plasma level of zinc and copper. 
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The kidneys are vital organs that perform a variety of 
important functions. The most prominent functions are 
removal of unwanted substances from plasma (both waste 
and surplus), homeostasis (maintenance of equilibrium) of 
the body’s water, electrolyte and acid base status, and 
participation in hormonal regulation. 1 
The renal failure may be acute or chronic, acute renal 
failure is a sudden, sharp decline in renal function as a 
result of an acute toxic or hypoxic insult to the kidneys, 
defined as occurring when the GFR is reduced to less than 
10 mL/minute. This syndrome is subdivided into three 
types, depending on the location of the precipitating defect. 
And chronic kidney disease (CKD) is a clinical syndrome 
that occurs when there is a gradual decline in renal 
function over time. According to the 2007 U.S. Renal Data 
System (USRDS) Annual Data Report, one in nine U.S. adults 
have CKD and 20 million more are at risk. [2] Early detection 
and treatment are needed to prevent progression to ESRD 
and complications such as coronary vascular disease. The 
National Kidney Foundation has formulated guidelines for 
earlier diagnosis, treatment, and prevention of further 
disease progression. GFR and evidence of kidney damage 
based on measurement of proteinuria or other markers 
form the basis of the classifications. [3] The conditions that 
can precipitate acute renal failure also may lead to chronic 
renal failure. 4,5 
The essential trace elements are usually associated with an 
enzyme (metalloenzyme) or another protein 
(metalloprotein) as an essential component or cofactor. 
Deficiencies typically impair one or more biochemical 
functions and excess concentrations are associated with at 
least some degree of toxicity. [1] Although trace elements, 
such as iron, copper, and zinc, are found in mg/L 
concentrations. An element is considered essential if a 
deficiency impairs a biochemical or functional process and 
replacement of the element corrects this impairment. 
Decreased intake, impaired absorption, increased 
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excretion, and genetic abnormalities are examples of 
conditions that could result in deficiency of trace elements. 
The cells of the proximal renal tubule have an important 
role in the homeostasis of essential metals, and the kidney 
is a target site for metal toxicity. 6 For this reason, and 
because of their close chemical similarity and extensive 
biological interaction, they are often considered together. 7 
MATERIAL AND METHODS 
This study was designed as a comparative analytical study, 
specifically it is case control study, and this study was 
conducted in Khartoum state, in Ribat University hospital. 
This study was carried out during the period from March 
2018 to June 2018.This study was included one hundred 
blood samples. 60 of these samples were collected from 
Sudanese patient with chronic renal failure for different 
duration, age and including both males and females and 40 
samples were collected from apparently healthy Sudanese 
individuals as control group. All volunteers was enrolled 
after being fully informed by the aim study, more over an 
informed consent was taken from every volunteer. A total 
of 60 blood samples from patient with renal failure the 
males were 38 with 63% while the rests 22 were females 
with 37%, the age of population studied ranged between 
17–90 years. Two and half ml of venous blood were 
collected by using sterile disposable syringes and poured 
into lithium heparin containers, immediately centrifuged 
and plasma was separated. And the plasma levels of zinc 
and copper determined by the use of atomic absorption 
spectrophotometer (OPERATOR’S MANUAL January 2003 
VER 3.94 C) 
Ethical Consideration 
Ethical approval was obtained from ethical committee of 
Shendi University and Informed consent will be taken from 
all the participants prior to their inclusion in the study. All 
the procedures will inform to the patients in their native 
language and informed written consent will be taken from 
them. 
Sampling Procedure 
Two and half ml of venous blood were collected by using 
sterile disposable syringes and poured into lithium heparin 
containers, immediately centrifuged and plasma was 
separated. 
Quality Control 
The precision and accuracy of all methods use in this study 
were checked at each batch using commercially prepared 
control sera. 
Statistical analysis 
Collected data were computed and analyzed by using the 
application of SPSS (statistical package for social sciences) 




Table 1: Comparison between the means of plasma Zinc in control group and in case group 
Study group Number Mean (mg/L) Std. Deviation P. value 
Case 60 0.3 0.17  
0.002 Control 40 0.7 0.14 
 
Table 2: Comparison between the means of plasma Copper in control group and in case group 
Study group Number Mean (mg/L) Std. Deviation P. value 
Case 60 0.5 0.30  
0.019 Control 40 0.7 0.13 
 
Table 3: Comparison between the means of plasma Zinc and Copper in patient with age less than 40 years and in patient with 
age more than 40 years 
Element 
trace 
Age P. value 
Less than 40 years More than 40 years 
No Mean (mg/L) Std. Deviation No Mean (mg/L) Std. Deviation 
Copper 19 0.5 0.28 41 0.5 0.31 0.527 
Zinc 19 0.2 0.16 41 0.3 0.18 0.434 
 
Table 4: Comparison between the means of plasma Zinc and Copper in male and in female patient 
Element 
trace 
Gender P. value 
Male Female 
No Mean (mg/L) Std. Deviation No Mean (mg/L) Std. Deviation 
Copper 38 0.4 0.29 22 0.6 0.30 0.667 
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Table 5: Comparison between the means of plasma Zinc and Copper in patient having a disease less than 6 years and patient 
having a disease more than 6 years 
Element 
trace 
Duration of disease P. value 
Less than 6 years More than 6 years 
No Mean (mg/L) Std. Deviation No Mean (mg/L) Std. Deviation 
Copper 41 0.5 0.30 19 0.4 0.28 0.621 




The present study was carried out to investigate trace 
element (zinc and copper) among chronic renal failure 
patients in Ribat University Hospital, during the period 
from March to June 2018; 100 blood samples were 
collected, a 60 of these samples were collected from patient 
with renal failure as test group, and 40 samples were 
collected from health individual as control group. 
The present study showed statically significant difference 
between the mean of the plasma levels of zinc and copper 
of the test group when compared with that of the control 
group, both are decreased. That illustrated in tables 4.1 and 
4.2. This agrees with (G. Murugan 2007) who was reported 
statically significant changes in the zinc metabolism. This 
was evidenced by statistically significant decrease in serum 
zinc levels in the study group suggesting zinc deficiency. 
Also similar study cared in India by (Z. Ghoreshi, S.K. 
Ahaley, et al, 2011) agree with serum zinc level, who report 
significant decreased in serum zinc level and disagree with 
serum copper level, who+ report no significant effect on 
serum copper level. 8, 9 
The results of this study showed insignificant difference 
between the plasma levels of zinc and copper of the test 
group according to the age. That illustrated in table 4.3. 
And also according to the gender. That illustrated in table 
4.4. This agree with (G. Murugan 2007) who was reported 
statically no significant influence of age and sex on zinc 
levels when compare of serum zinc status between age and 
sex of study group. 8 
Also the results of this study showed that there was 
insignificant difference between the plasma levels of zinc 
and copper of the test group according to the duration of 
disease with. That illustrated in table 4.5. 
CONCLUSION 
The plasma level of zinc and copper was affected by the 
renal failure, the plasma level of zinc and copper are low in 
patient with renal failure. And the age and gender of the 
patient have no significant effect on the plasma level of zinc 
and copper also the duration of the disease have no effect. 
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